The U.S. Supreme Court issued three decisions Thursday, but none of them were Mutual Pharmaceutical Co., v. Bartlett, 12-142.
Mutual used to be a private, stand-alone Philadelphia company, founded in 1947. But since the case began, it was sold to Takeda Pharmaceuticals and then Sun Pharmaceuticals, so Sun inherits the ligation. The case involves whether federal law regarding FDA rules supersede a patient's ability to sue a generic drug company for product design in state court. A New Hampshire woman, Karen Bartlett, suffered a horrible reaction to a generic drug made by Mutual.
A previous Inquirer story, in advance of oral arguments, is here.